Meningiomas in children and adolescents: a meta-analysis of individual patient data
The epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been drawn from small case series and extrapolation from adult studies. This study was done to pool and analyse the clinical evidence on child and adolescent mening...
Saved in:
| Published in | The lancet oncology Vol. 12; no. 13; pp. 1229 - 1239 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
01.12.2011
Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been drawn from small case series and extrapolation from adult studies. This study was done to pool and analyse the clinical evidence on child and adolescent meningioma.
Searches of PubMed, Medline, and Embase identified 35 case series of child and adolescent meningioma completed over the past 21 years. Individual patient data were obtained from 30 studies via direct communication with investigators. Primary outcomes were relapse-free survival (RFS) and overall survival. Prognostic variables were extent of initial surgery, use of upfront radiotherapy, age, sex, presence of neurofibromatosis, tumour location, and tumour grade. RFS and overall survival were analysed using Kaplan-Meier survival curves and multivariable Cox regression models.
From a total of 677 children and adolescents with meningioma, 518 were eligible for RFS analysis and 547 for overall survival analysis. Multivariable analysis showed that patients who underwent initial gross-total resection had better RFS (hazard ratio 0·16, 95% CI 0·10–0·25; p<0·0001) and overall survival (0·21, 0·11–0·39; p<0·0001) than those who had subtotal resection. No significant benefit was seen for upfront radiotherapy in terms of RFS (0·59, 0·30–1·16; p=0·128) or overall survival (1·10, 0·53–2·28; p=0·791). Patients with neurofibromatosis type 2 (NF2) had worse RFS than those without neurofibromatosis (2·36, 1·23–4·51; p=0·010). There was a significant change in overall survival with time between patients with NF2 compared with those without neurofibromatosis (1·45, 1·09–1·92; p=0·011); although overall survival was initially better for patients with NF2 than for those without neurofibromatosis, overall survival at 10 years was worse for patients with NF2. Patients with WHO grade III tumours had worse RFS than those with WHO grade I (3·90, 2·10–7·26; p<0·0001) and grade II tumours (2·49, 1·11–5·56; p=0·027).
Extent of initial surgical resection is the strongest independent prognostic factor for child and adolescent meningioma. No benefit for upfront radiotherapy was noted. Hence, aggressive surgical management, to achieve gross-total resection, is the initial treatment of choice. In the event of a subtotal resection, repeat resection is recommended to achieve maximum extirpation. Close observation is warranted for patients who have a subtotal resection or who have WHO grade III tumours. Patients without neurofibromatosis should have a minimum 10-year follow-up, whereas patients with NF2 should be considered a special risk category, necessitating life-long follow-up.
None. |
|---|---|
| AbstractList | Summary Background The epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been drawn from small case series and extrapolation from adult studies. This study was done to pool and analyse the clinical evidence on child and adolescent meningioma. Methods Searches of PubMed, Medline, and Embase identified 35 case series of child and adolescent meningioma completed over the past 21 years. Individual patient data were obtained from 30 studies via direct communication with investigators. Primary outcomes were relapse-free survival (RFS) and overall survival. Prognostic variables were extent of initial surgery, use of upfront radiotherapy, age, sex, presence of neurofibromatosis, tumour location, and tumour grade. RFS and overall survival were analysed using Kaplan-Meier survival curves and multivariable Cox regression models. Findings From a total of 677 children and adolescents with meningioma, 518 were eligible for RFS analysis and 547 for overall survival analysis. Multivariable analysis showed that patients who underwent initial gross-total resection had better RFS (hazard ratio 0·16, 95% CI 0·10–0·25; p<0·0001) and overall survival (0·21, 0·11–0·39; p<0·0001) than those who had subtotal resection. No significant benefit was seen for upfront radiotherapy in terms of RFS (0·59, 0·30–1·16; p=0·128) or overall survival (1·10, 0·53–2·28; p=0·791). Patients with neurofibromatosis type 2 (NF2) had worse RFS than those without neurofibromatosis (2·36, 1·23–4·51; p=0·010). There was a significant change in overall survival with time between patients with NF2 compared with those without neurofibromatosis (1·45, 1·09–1·92; p=0·011); although overall survival was initially better for patients with NF2 than for those without neurofibromatosis, overall survival at 10 years was worse for patients with NF2. Patients with WHO grade III tumours had worse RFS than those with WHO grade I (3·90, 2·10–7·26; p<0·0001) and grade II tumours (2·49, 1·11–5·56; p=0·027). Interpretation Extent of initial surgical resection is the strongest independent prognostic factor for child and adolescent meningioma. No benefit for upfront radiotherapy was noted. Hence, aggressive surgical management, to achieve gross-total resection, is the initial treatment of choice. In the event of a subtotal resection, repeat resection is recommended to achieve maximum extirpation. Close observation is warranted for patients who have a subtotal resection or who have WHO grade III tumours. Patients without neurofibromatosis should have a minimum 10-year follow-up, whereas patients with NF2 should be considered a special risk category, necessitating life-long follow-up. Funding None. The epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been drawn from small case series and extrapolation from adult studies. This study was done to pool and analyse the clinical evidence on child and adolescent meningioma. Searches of PubMed, Medline, and Embase identified 35 case series of child and adolescent meningioma completed over the past 21 years. Individual patient data were obtained from 30 studies via direct communication with investigators. Primary outcomes were relapse-free survival (RFS) and overall survival. Prognostic variables were extent of initial surgery, use of upfront radiotherapy, age, sex, presence of neurofibromatosis, tumour location, and tumour grade. RFS and overall survival were analysed using Kaplan-Meier survival curves and multivariable Cox regression models. From a total of 677 children and adolescents with meningioma, 518 were eligible for RFS analysis and 547 for overall survival analysis. Multivariable analysis showed that patients who underwent initial gross-total resection had better RFS (hazard ratio 0·16, 95% CI 0·10-0·25; p<0·0001) and overall survival (0·21, 0·11-0·39; p<0·0001) than those who had subtotal resection. No significant benefit was seen for upfront radiotherapy in terms of RFS (0·59, 0·30-1·16; p=0·128) or overall survival (1·10, 0·53-2·28; p=0·791). Patients with neurofibromatosis type 2 (NF2) had worse RFS than those without neurofibromatosis (2·36, 1·23-4·51; p=0·010). There was a significant change in overall survival with time between patients with NF2 compared with those without neurofibromatosis (1·45, 1·09-1·92; p=0·011); although overall survival was initially better for patients with NF2 than for those without neurofibromatosis, overall survival at 10 years was worse for patients with NF2. Patients with WHO grade III tumours had worse RFS than those with WHO grade I (3·90, 2·10-7·26; p<0·0001) and grade II tumours (2·49, 1·11-5·56; p=0·027). Extent of initial surgical resection is the strongest independent prognostic factor for child and adolescent meningioma. No benefit for upfront radiotherapy was noted. Hence, aggressive surgical management, to achieve gross-total resection, is the initial treatment of choice. In the event of a subtotal resection, repeat resection is recommended to achieve maximum extirpation. Close observation is warranted for patients who have a subtotal resection or who have WHO grade III tumours. Patients without neurofibromatosis should have a minimum 10-year follow-up, whereas patients with NF2 should be considered a special risk category, necessitating life-long follow-up. None. The epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been drawn from small case series and extrapolation from adult studies. This study was done to pool and analyse the clinical evidence on child and adolescent meningioma. Searches of PubMed, Medline, and Embase identified 35 case series of child and adolescent meningioma completed over the past 21 years. Individual patient data were obtained from 30 studies via direct communication with investigators. Primary outcomes were relapse-free survival (RFS) and overall survival. Prognostic variables were extent of initial surgery, use of upfront radiotherapy, age, sex, presence of neurofibromatosis, tumour location, and tumour grade. RFS and overall survival were analysed using Kaplan-Meier survival curves and multivariable Cox regression models. From a total of 677 children and adolescents with meningioma, 518 were eligible for RFS analysis and 547 for overall survival analysis. Multivariable analysis showed that patients who underwent initial gross-total resection had better RFS (hazard ratio 0·16, 95% CI 0·10–0·25; p<0·0001) and overall survival (0·21, 0·11–0·39; p<0·0001) than those who had subtotal resection. No significant benefit was seen for upfront radiotherapy in terms of RFS (0·59, 0·30–1·16; p=0·128) or overall survival (1·10, 0·53–2·28; p=0·791). Patients with neurofibromatosis type 2 (NF2) had worse RFS than those without neurofibromatosis (2·36, 1·23–4·51; p=0·010). There was a significant change in overall survival with time between patients with NF2 compared with those without neurofibromatosis (1·45, 1·09–1·92; p=0·011); although overall survival was initially better for patients with NF2 than for those without neurofibromatosis, overall survival at 10 years was worse for patients with NF2. Patients with WHO grade III tumours had worse RFS than those with WHO grade I (3·90, 2·10–7·26; p<0·0001) and grade II tumours (2·49, 1·11–5·56; p=0·027). Extent of initial surgical resection is the strongest independent prognostic factor for child and adolescent meningioma. No benefit for upfront radiotherapy was noted. Hence, aggressive surgical management, to achieve gross-total resection, is the initial treatment of choice. In the event of a subtotal resection, repeat resection is recommended to achieve maximum extirpation. Close observation is warranted for patients who have a subtotal resection or who have WHO grade III tumours. Patients without neurofibromatosis should have a minimum 10-year follow-up, whereas patients with NF2 should be considered a special risk category, necessitating life-long follow-up. None. The epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been drawn from small case series and extrapolation from adult studies. This study was done to pool and analyse the clinical evidence on child and adolescent meningioma.BACKGROUNDThe epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been drawn from small case series and extrapolation from adult studies. This study was done to pool and analyse the clinical evidence on child and adolescent meningioma.Searches of PubMed, Medline, and Embase identified 35 case series of child and adolescent meningioma completed over the past 21 years. Individual patient data were obtained from 30 studies via direct communication with investigators. Primary outcomes were relapse-free survival (RFS) and overall survival. Prognostic variables were extent of initial surgery, use of upfront radiotherapy, age, sex, presence of neurofibromatosis, tumour location, and tumour grade. RFS and overall survival were analysed using Kaplan-Meier survival curves and multivariable Cox regression models.METHODSSearches of PubMed, Medline, and Embase identified 35 case series of child and adolescent meningioma completed over the past 21 years. Individual patient data were obtained from 30 studies via direct communication with investigators. Primary outcomes were relapse-free survival (RFS) and overall survival. Prognostic variables were extent of initial surgery, use of upfront radiotherapy, age, sex, presence of neurofibromatosis, tumour location, and tumour grade. RFS and overall survival were analysed using Kaplan-Meier survival curves and multivariable Cox regression models.From a total of 677 children and adolescents with meningioma, 518 were eligible for RFS analysis and 547 for overall survival analysis. Multivariable analysis showed that patients who underwent initial gross-total resection had better RFS (hazard ratio 0·16, 95% CI 0·10-0·25; p<0·0001) and overall survival (0·21, 0·11-0·39; p<0·0001) than those who had subtotal resection. No significant benefit was seen for upfront radiotherapy in terms of RFS (0·59, 0·30-1·16; p=0·128) or overall survival (1·10, 0·53-2·28; p=0·791). Patients with neurofibromatosis type 2 (NF2) had worse RFS than those without neurofibromatosis (2·36, 1·23-4·51; p=0·010). There was a significant change in overall survival with time between patients with NF2 compared with those without neurofibromatosis (1·45, 1·09-1·92; p=0·011); although overall survival was initially better for patients with NF2 than for those without neurofibromatosis, overall survival at 10 years was worse for patients with NF2. Patients with WHO grade III tumours had worse RFS than those with WHO grade I (3·90, 2·10-7·26; p<0·0001) and grade II tumours (2·49, 1·11-5·56; p=0·027).FINDINGSFrom a total of 677 children and adolescents with meningioma, 518 were eligible for RFS analysis and 547 for overall survival analysis. Multivariable analysis showed that patients who underwent initial gross-total resection had better RFS (hazard ratio 0·16, 95% CI 0·10-0·25; p<0·0001) and overall survival (0·21, 0·11-0·39; p<0·0001) than those who had subtotal resection. No significant benefit was seen for upfront radiotherapy in terms of RFS (0·59, 0·30-1·16; p=0·128) or overall survival (1·10, 0·53-2·28; p=0·791). Patients with neurofibromatosis type 2 (NF2) had worse RFS than those without neurofibromatosis (2·36, 1·23-4·51; p=0·010). There was a significant change in overall survival with time between patients with NF2 compared with those without neurofibromatosis (1·45, 1·09-1·92; p=0·011); although overall survival was initially better for patients with NF2 than for those without neurofibromatosis, overall survival at 10 years was worse for patients with NF2. Patients with WHO grade III tumours had worse RFS than those with WHO grade I (3·90, 2·10-7·26; p<0·0001) and grade II tumours (2·49, 1·11-5·56; p=0·027).Extent of initial surgical resection is the strongest independent prognostic factor for child and adolescent meningioma. No benefit for upfront radiotherapy was noted. Hence, aggressive surgical management, to achieve gross-total resection, is the initial treatment of choice. In the event of a subtotal resection, repeat resection is recommended to achieve maximum extirpation. Close observation is warranted for patients who have a subtotal resection or who have WHO grade III tumours. Patients without neurofibromatosis should have a minimum 10-year follow-up, whereas patients with NF2 should be considered a special risk category, necessitating life-long follow-up.INTERPRETATIONExtent of initial surgical resection is the strongest independent prognostic factor for child and adolescent meningioma. No benefit for upfront radiotherapy was noted. Hence, aggressive surgical management, to achieve gross-total resection, is the initial treatment of choice. In the event of a subtotal resection, repeat resection is recommended to achieve maximum extirpation. Close observation is warranted for patients who have a subtotal resection or who have WHO grade III tumours. Patients without neurofibromatosis should have a minimum 10-year follow-up, whereas patients with NF2 should be considered a special risk category, necessitating life-long follow-up.None.FUNDINGNone. |
| Author | Hung, Po-Cheng Devi, B Indira Lund-Johansen, Morten Rorke-Adams, Lucy B Mehta, Nirav Zwerdling, Ted Kotecha, Rishi S Li, Xin Amirjamshidi, Abbas Gao, Xing Liu, Yuguang Cole, Catherine H Rushing, Elisabeth J Lakhdar, Fayçal Gjerris, Flemming Gottardo, Nicholas G Sudhir, B Jayanand Pascoe, Elaine M Greene, Stephanie Kim, Seung-Ki Lima, Marco A |
| Author_xml | – sequence: 1 givenname: Rishi S surname: Kotecha fullname: Kotecha, Rishi S email: rishi_k28@hotmail.com organization: Department of Haematology and Oncology, Princess Margaret Hospital for Children, Perth, WA, Australia – sequence: 2 givenname: Elaine M surname: Pascoe fullname: Pascoe, Elaine M organization: Department of Clinical Research and Education, Princess Margaret Hospital for Children, Perth, WA, Australia – sequence: 3 givenname: Elisabeth J surname: Rushing fullname: Rushing, Elisabeth J organization: Institut für Neuropathologie, UniversitätsSpital Zürich, Zürich, Switzerland – sequence: 4 givenname: Lucy B surname: Rorke-Adams fullname: Rorke-Adams, Lucy B organization: Department of Neuropathology, The Children's Hospital of Philadelphia, and School of Medicine, University of Pennsylvania, Philadelphia, PA, USA – sequence: 5 givenname: Ted surname: Zwerdling fullname: Zwerdling, Ted organization: Department of Paediatrics, Section Haematology and Oncology, University of California Davis Medical Centre, Sacramento, CA, USA – sequence: 6 givenname: Xing surname: Gao fullname: Gao, Xing organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China – sequence: 7 givenname: Xin surname: Li fullname: Li, Xin organization: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China – sequence: 8 givenname: Stephanie surname: Greene fullname: Greene, Stephanie organization: Department of Neurological Surgery, University of Pittsburgh Medical School, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA – sequence: 9 givenname: Abbas surname: Amirjamshidi fullname: Amirjamshidi, Abbas organization: Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran – sequence: 10 givenname: Seung-Ki surname: Kim fullname: Kim, Seung-Ki organization: Division of Paediatric Neurosurgery, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea – sequence: 11 givenname: Marco A surname: Lima fullname: Lima, Marco A organization: Department of Neurosurgery, National Cancer Institute, Rio de Janeiro, Brazil – sequence: 12 givenname: Po-Cheng surname: Hung fullname: Hung, Po-Cheng organization: Department of Paediatric Neurology, Chang Gung Memorial Hospital, Chang Gung Children's Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan – sequence: 13 givenname: Fayçal surname: Lakhdar fullname: Lakhdar, Fayçal organization: Department of Neurosurgery, Hôpital des Spécialités, Rabat, Morocco – sequence: 14 givenname: Nirav surname: Mehta fullname: Mehta, Nirav organization: Department of Neurosurgery, Bombay Hospital Institute of Medical Sciences, Mumbai, India – sequence: 15 givenname: Yuguang surname: Liu fullname: Liu, Yuguang organization: Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China – sequence: 16 givenname: B Indira surname: Devi fullname: Devi, B Indira organization: Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bangalore, India – sequence: 17 givenname: B Jayanand surname: Sudhir fullname: Sudhir, B Jayanand organization: Department of Neurosurgery, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India – sequence: 18 givenname: Morten surname: Lund-Johansen fullname: Lund-Johansen, Morten organization: Department of Neurosurgery, Haukeland University Hospital, and Institute of Surgical Science, University of Bergen, Bergen, Norway – sequence: 19 givenname: Flemming surname: Gjerris fullname: Gjerris, Flemming organization: University Clinic of Neurosurgery, Neuroscience Centre, Rigshospitalet, Capital Region, Copenhagen, Denmark – sequence: 20 givenname: Catherine H surname: Cole fullname: Cole, Catherine H organization: Department of Haematology and Oncology, Princess Margaret Hospital for Children, Perth, WA, Australia – sequence: 21 givenname: Nicholas G surname: Gottardo fullname: Gottardo, Nicholas G organization: Department of Haematology and Oncology, Princess Margaret Hospital for Children, Perth, WA, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22094004$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkU1v1DAQhiNURD_gJ4AiLpRDYMZO4gQEFar4koo4FM6W156Ai9de7KTS_nucTcthJVROtqxnHs-8c1wc-OCpKB4jvEDA9uUl1gIqBnVzivhcABNNxe8VR_m5rpq66w529wU5LI5TugJAgdA8KA4Zg74GqI-Kyy_krf9hw1ql0vpS_7TORPKl8qZUJjhKmvyYXpWqXNOoKuWV2yabyjBk3thrayblyo0abeZKo0b1sLg_KJfo0c15Unz_8P7b-afq4uvHz-fvLirdAIxVC6iHtgU9iK5ZcSTGa9KcsboTnehXyrAOscW-XwFDTcxoLrpeEAOFXHF-UjxbvJsYfk-URrm2uVvnlKcwJdmDAC6gaTL5dI-8ClPMk8xQVzPeM8zQkxtoWq3JyE20axW38jasDLxeAB1DSpEGqe2Y5w5-jMo6iSDn1cjdauScu0SUu9XIudtmr_r2g7vqzpY6ylFeW4oy6Ry1JmMj6VGaYO80vN0zaGe91cr9oi2lv1GgTEzCIpkdiDvDLHjzb8F_NPAHtdPLDA |
| CODEN | LANCAO |
| CitedBy_id | crossref_primary_10_1038_nrneurol_2013_48 crossref_primary_10_1002_pbc_28919 crossref_primary_10_4103_jpn_JPN_264_20 crossref_primary_10_3171_CASE2026 crossref_primary_10_1002_cam4_426 crossref_primary_10_1159_000446442 crossref_primary_10_1016_j_wneu_2018_12_200 crossref_primary_10_1016_j_neuarg_2016_04_001 crossref_primary_10_1007_s00381_024_06684_2 crossref_primary_10_1016_j_wneu_2020_09_044 crossref_primary_10_7887_jcns_21_801 crossref_primary_10_1016_j_anndiagpath_2020_151516 crossref_primary_10_1007_s10143_017_0884_2 crossref_primary_10_1016_j_braindev_2013_01_007 crossref_primary_10_1111_bpa_12884 crossref_primary_10_1111_neup_12426 crossref_primary_10_1177_0883073816664669 crossref_primary_10_1007_s11060_019_03191_2 crossref_primary_10_1007_s11060_024_04917_7 crossref_primary_10_1007_s00381_012_1906_6 crossref_primary_10_1016_j_ijscr_2022_107364 crossref_primary_10_3171_2017_2_PEDS16497 crossref_primary_10_1007_s00381_021_05296_4 crossref_primary_10_1093_noajnl_vdac056 crossref_primary_10_1007_s00381_012_1823_8 crossref_primary_10_1016_j_ijms_2014_06_024 crossref_primary_10_1097_SCS_0000000000007509 crossref_primary_10_25259_SNI_365_2022 crossref_primary_10_1038_s41598_022_05773_z crossref_primary_10_1007_s10014_016_0271_7 crossref_primary_10_7759_cureus_31213 crossref_primary_10_1007_s00381_016_3269_x crossref_primary_10_1093_neuros_nyaa355 crossref_primary_10_1016_j_neuro_2016_05_009 crossref_primary_10_3171_2021_1_PEDS20819 crossref_primary_10_1016_j_neuchi_2019_10_007 crossref_primary_10_1016_j_clineuro_2020_105799 crossref_primary_10_1016_j_crad_2020_12_011 crossref_primary_10_1265_ehpm_24_00216 crossref_primary_10_1016_S1470_2045_11_70304_7 crossref_primary_10_1007_s11060_012_0884_6 crossref_primary_10_7759_cureus_12701 crossref_primary_10_3171_2017_3_PEDS16502 crossref_primary_10_1080_02688697_2020_1726286 crossref_primary_10_1007_s00701_016_2900_7 crossref_primary_10_4132_jptm_2019_11_05 crossref_primary_10_1002_cncr_28366 crossref_primary_10_1055_s_0044_1787533 crossref_primary_10_1093_neuonc_nos267 crossref_primary_10_3171_2012_7_PEDS12179 crossref_primary_10_1007_s11060_013_1067_9 crossref_primary_10_1016_j_jocn_2016_10_009 crossref_primary_10_25259_SNI_131_2023 crossref_primary_10_1016_j_jocn_2020_01_044 crossref_primary_10_1007_s11060_023_04344_0 crossref_primary_10_1016_S1470_2045_13_70107_4 crossref_primary_10_1093_neuonc_noae082 crossref_primary_10_1007_s11060_020_03649_8 crossref_primary_10_1186_s12871_022_01836_w crossref_primary_10_1227_neu_0000000000002543 crossref_primary_10_1227_NEU_0000000000000133 crossref_primary_10_1186_s40478_025_01925_0 crossref_primary_10_1159_000500765 crossref_primary_10_1007_s11940_019_0587_9 crossref_primary_10_1007_s11060_018_2756_1 crossref_primary_10_1007_s11060_020_03683_6 crossref_primary_10_1007_s00381_012_1991_6 crossref_primary_10_3892_etm_2013_1147 crossref_primary_10_18705_2782_38062023_3_3_48_63 crossref_primary_10_1007_s00381_014_2490_8 crossref_primary_10_1007_s00381_016_3278_9 crossref_primary_10_1007_s00381_012_1840_7 crossref_primary_10_1016_j_nic_2021_05_010 crossref_primary_10_3892_mco_2017_1375 crossref_primary_10_1097_PAS_0000000000001597 crossref_primary_10_1002_ccr3_7927 crossref_primary_10_1007_s00381_015_2784_5 crossref_primary_10_1055_s_0037_1604037 crossref_primary_10_1016_j_wneu_2016_04_098 crossref_primary_10_1007_s00381_014_2558_5 crossref_primary_10_1186_s41016_017_0085_4 crossref_primary_10_1007_s00381_019_04472_x crossref_primary_10_1007_s10143_016_0716_9 crossref_primary_10_3389_fonc_2020_01523 crossref_primary_10_1016_j_clineuro_2013_12_019 crossref_primary_10_1007_s00381_022_05553_0 crossref_primary_10_1007_s11910_013_0337_4 crossref_primary_10_3340_jkns_2015_0609_001 crossref_primary_10_1007_s00381_024_06708_x crossref_primary_10_3389_fonc_2021_709321 crossref_primary_10_7243_2052_6946_2_1 crossref_primary_10_1155_2013_375139 crossref_primary_10_1016_j_wneu_2019_11_093 crossref_primary_10_1007_s00381_017_3362_9 crossref_primary_10_12688_f1000research_157842_1 crossref_primary_10_1007_s10048_015_0472_y crossref_primary_10_1007_s00701_018_3727_1 crossref_primary_10_1016_j_wneu_2017_09_161 crossref_primary_10_3171_CASE21107 crossref_primary_10_1016_j_wneu_2021_06_139 crossref_primary_10_1186_s41016_022_00299_9 crossref_primary_10_1007_s00381_012_1759_z crossref_primary_10_1007_s00381_019_04156_6 crossref_primary_10_1016_j_ijpam_2014_11_001 crossref_primary_10_3390_cancers15184447 crossref_primary_10_21294_1814_4861_2022_21_4_110_123 crossref_primary_10_3390_life13122284 crossref_primary_10_1007_s00701_015_2495_4 crossref_primary_10_1016_j_wneu_2016_09_094 |
| Cites_doi | 10.1200/JCO.1995.13.1.112 10.1007/BF00571115 10.1007/s002340050794 10.1007/s00701-009-0206-8 10.1093/jnen/60.10.994 10.1200/JCO.1999.17.3.832 10.7326/0003-4819-151-4-200908180-00136 10.1007/s11940-006-0022-x 10.1056/NEJMoa0902579 10.1159/000084858 10.1007/s11060-010-0503-3 10.1159/000149903 10.1159/000113112 10.3171/jns.1998.89.1.0052 10.1007/s00401-007-0243-4 10.1007/s003810100507 10.1097/00043426-200203000-00008 10.1016/j.pediatrneurol.2008.08.004 10.1016/S0090-3019(97)00343-1 10.1007/s11060-009-9934-0 10.1016/0090-3019(95)00451-3 10.1007/BF00165652 10.1007/s00381-001-0516-5 10.1159/000120790 10.3171/jns.1994.80.3.0447 10.1038/sj.bjc.6600609 10.4103/1817-1745.57322 10.1159/000110656 10.1007/s00381-009-0964-x 10.1007/s11060-010-0348-9 10.1007/s00381-009-0949-9 10.1007/s11060-010-0368-5 10.1159/000120637 10.1038/sj.bjc.6603278 10.1007/s11060-010-0339-x 10.1007/BF00261651 10.1016/S1470-2045(08)70342-5 10.1002/1097-0142(19890315)63:6<1205::AID-CNCR2820630627>3.0.CO;2-U 10.1080/02688690701842208 10.1016/S1130-1473(08)70210-0 10.1159/000110661 10.1016/S0344-0338(00)80095-3 10.1177/08830738060210010801 10.1007/s11060-010-0343-1 10.1080/02688699745655 10.1016/j.neuchi.2010.05.008 10.3109/02688698909002794 10.1007/s003819900205 |
| ContentType | Journal Article |
| Copyright | 2011 Elsevier Ltd Elsevier Ltd Copyright © 2011 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited Dec 2011 |
| Copyright_xml | – notice: 2011 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2011 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited Dec 2011 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 0TZ 3V. 7RV 7TO 7X7 7XB 88E 8AO 8C1 8C2 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 |
| DOI | 10.1016/S1470-2045(11)70275-3 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Pharma and Biotech Premium PRO ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database (ProQuest) Lancet Titles Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Pharma and Biotech Premium PRO Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) Lancet Titles ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Pharma and Biotech Premium PRO MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1474-5488 |
| EndPage | 1239 |
| ExternalDocumentID | 2526905141 22094004 10_1016_S1470_2045_11_70275_3 S1470204511702753 1_s2_0_S1470204511702753 |
| Genre | Meta-Analysis Journal Article Review |
| GrantInformation | None. |
| GroupedDBID | --- --K --M -RU .1- .55 .FO 0R~ 123 1B1 1P~ 1~5 29L 4.4 457 4CK 4G. 53G 5VS 6PF 7-5 71M 7RV 7X7 88E 8AO 8C1 8C2 8FI 8FJ AAEDT AAEDW AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABMAC ABMZM ABUWG ABWVN ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO AEIPS AEKER AENEX AEUPX AEVXI AFKRA AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BENPR BKEYQ BKOJK BNPGV BPHCQ BVXVI CCPQU CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA HMCUK HVGLF HZ~ IHE J1W KOM M1P M41 MO0 N9A NAPCQ O-L O9- OC~ OO- OZT P-8 P-9 P2P PCD PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO R2- ROL RPZ SDG SEL SES SPCBC SSH SSZ T5K TLN UKHRP UV1 WOW X7M XBR Z5R 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW RIG SDF ABLVK ABYKQ AHPSJ AJBFU ZA5 AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 0TZ 7TO 7XB 8FK H94 K9. PKEHL PQEST PQUKI 7X8 |
| ID | FETCH-LOGICAL-c500t-601cf660cf785b31e234ec322487879bad28116199b021ce2dc37897e20a13a33 |
| IEDL.DBID | 7X7 |
| ISSN | 1470-2045 1474-5488 |
| IngestDate | Sun Aug 24 04:04:18 EDT 2025 Fri Jul 25 05:05:39 EDT 2025 Mon Jul 21 06:04:38 EDT 2025 Tue Jul 01 04:04:38 EDT 2025 Thu Apr 24 22:59:11 EDT 2025 Fri Feb 23 02:29:55 EST 2024 Sun Feb 23 10:18:55 EST 2025 Tue Aug 26 16:32:31 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 13 |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2011 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c500t-601cf660cf785b31e234ec322487879bad28116199b021ce2dc37897e20a13a33 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Feature-3 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 22094004 |
| PQID | 908423921 |
| PQPubID | 46089 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_907037055 proquest_journals_908423921 pubmed_primary_22094004 crossref_citationtrail_10_1016_S1470_2045_11_70275_3 crossref_primary_10_1016_S1470_2045_11_70275_3 elsevier_sciencedirect_doi_10_1016_S1470_2045_11_70275_3 elsevier_clinicalkeyesjournals_1_s2_0_S1470204511702753 elsevier_clinicalkey_doi_10_1016_S1470_2045_11_70275_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2011-12-01 |
| PublicationDateYYYYMMDD | 2011-12-01 |
| PublicationDate_xml | – month: 12 year: 2011 text: 2011-12-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | The lancet oncology |
| PublicationTitleAlternate | Lancet Oncol |
| PublicationYear | 2011 |
| Publisher | Elsevier Ltd Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
| References | Ferrante, Acqui, Artico, Mastronardi, Fortuna (bib40) 1989; 3 Caroli, Russillo, Ferrante (bib41) 2006; 21 Yoon, Kim, Kim (bib18) 1999; 41 Li, Zhao (bib37) 2009; 25 Erdinçler, Lena, Sarioğlu, Kuday, Choux (bib44) 1998; 49 Amirjamshidi, Mehrazin, Abbassioun (bib19) 2000; 16 Choux, Lena, Genitori, Azambuja, Cunha, Dechambenoit (bib7) 1991 Perry (bib53) 2006 Schut, Canady, Sutton, Bruce (bib42) 1994; 20 Rochat, Johannesen, Gjerris (bib25) 2004; 100 Wolff, Sajedi, Brant, Coppes, Egeler (bib48) 2002; 87 Demirtaş, Erşahin, Yilmaz, Mutluer, Veral (bib20) 2000; 196 Menon, Nair, Sudhir, Rao, Mathew, Bahuleyan (bib35) 2009; 151 Plotkin, Stemmer-Rachamimov, Barker (bib55) 2009; 361 Alexiou, Mpairamidis, Psarros, Sfakianos, Prodromou (bib34) 2008; 44 Sheikh, Siqueira, Dayel (bib14) 1996; 45 Mehta, Bhagwati, Parulekar (bib38) 2009; 4 Traunecker, Mallucci, Grundy, Pizer, Saran (bib3) 2008; 22 Goutagny, Kalamarides (bib54) 2010; 99 Tufan, Dogulu, Kurt, Emmez, Ceviker, Baykaner (bib27) 2005; 41 Liu, Li, Zhu, Liu, Wu (bib31) 2008; 44 Greene, Nair, Ojemann, Ellenbogen, Avellino (bib29) 2008; 44 Kotecha, Junckerstorff, Lee, Cole, Gottardo (bib2) 2011; 104 Maranhão-Filho, Campos, Lima (bib33) 2008; 39 Gao, Zhang, Mao, Wang (bib36) 2009; 25 Darling, Byrd, Reyes-Mugica (bib10) 1994; 15 Mandai, Tamaki, Kurata, Eguchi (bib17) 1997; 25 Mallucci, Parkes, Barber (bib15) 1996; 12 Raaschou-Nielsen, Sørensen, Carstensen (bib28) 2006; 95 Lund-Johansen, Scheie, Muller, Lundar, Helseth (bib22) 2001; 17 Hanft, Canoll, Bruce (bib58) 2010; 99 Gottardo, Gajjar (bib50) 2006; 8 Wisoff, Boyett, Berger (bib47) 1998; 89 Germano, Edwards, Davis, Schiffer (bib11) 1994; 80 Teixidor, Guillén, Cruz, Costa (bib32) 2008; 19 Merchant, Li, Xiong, Kun, Boop, Sanford (bib46) 2009; 10 Durand, Labrousse, Jouvet (bib52) 2009; 95 Ferrante, Acqui, Artico, Mastronardi, Rocchi, Fortuna (bib5) 1989; 5 Louis, Ohgaki, Wiestler (bib45) 2007; 114 Lakhdar, Arkha, El Ouahabi (bib39) 2010; 56 Im, Wang, Kim (bib21) 2001; 17 Zwerdling, Dothage (bib24) 2002; 24 Zeltzer, Boyett, Finlay (bib49) 1999; 17 Gondi, Tome, Mehta (bib56) 2010; 99 Cushing, Eisenhardt (bib1) 1938 Hung, Wang, Chou, Sun, Huang (bib12) 1994; 35 Rogers, Gilbert, Vogelbaum (bib57) 2010; 99 Perilongo, Sutton, Goldwein (bib8) 1992; 18 Turgut, Özcan, Bertan (bib16) 1997; 11 Finlay, Boyett, Yates (bib51) 1995; 13 Baumgartner, Sorenson (bib13) 1996; 29 Liberati, Altman, Tetzlaff (bib4) 2009; 151 Arivazhagan, Devi, Kolluri, Abraham, Sampath, Chandramouli (bib30) 2008; 44 Davidson, Hope (bib6) 1989; 63 Glasier, Husain, Chadduck, Boop (bib9) 1993; 14 Hope, Armstrong, Babyn (bib43) 1992; 13 Rushing, Olsen, Mena (bib26) 2005; 103 Perry, Giannini, Raghavan (bib23) 2001; 60 Perilongo (10.1016/S1470-2045(11)70275-3_bib8) 1992; 18 Germano (10.1016/S1470-2045(11)70275-3_bib11) 1994; 80 Cushing (10.1016/S1470-2045(11)70275-3_bib1) 1938 Traunecker (10.1016/S1470-2045(11)70275-3_bib3) 2008; 22 Erdinçler (10.1016/S1470-2045(11)70275-3_bib44) 1998; 49 Demirtaş (10.1016/S1470-2045(11)70275-3_bib20) 2000; 196 Zwerdling (10.1016/S1470-2045(11)70275-3_bib24) 2002; 24 Rochat (10.1016/S1470-2045(11)70275-3_bib25) 2004; 100 Hung (10.1016/S1470-2045(11)70275-3_bib12) 1994; 35 Caroli (10.1016/S1470-2045(11)70275-3_bib41) 2006; 21 Greene (10.1016/S1470-2045(11)70275-3_bib29) 2008; 44 Darling (10.1016/S1470-2045(11)70275-3_bib10) 1994; 15 Finlay (10.1016/S1470-2045(11)70275-3_bib51) 1995; 13 Sheikh (10.1016/S1470-2045(11)70275-3_bib14) 1996; 45 Glasier (10.1016/S1470-2045(11)70275-3_bib9) 1993; 14 Merchant (10.1016/S1470-2045(11)70275-3_bib46) 2009; 10 Im (10.1016/S1470-2045(11)70275-3_bib21) 2001; 17 Schut (10.1016/S1470-2045(11)70275-3_bib42) 1994; 20 Plotkin (10.1016/S1470-2045(11)70275-3_bib55) 2009; 361 Hanft (10.1016/S1470-2045(11)70275-3_bib58) 2010; 99 Li (10.1016/S1470-2045(11)70275-3_bib37) 2009; 25 Liberati (10.1016/S1470-2045(11)70275-3_bib4) 2009; 151 Zeltzer (10.1016/S1470-2045(11)70275-3_bib49) 1999; 17 Rogers (10.1016/S1470-2045(11)70275-3_bib57) 2010; 99 Amirjamshidi (10.1016/S1470-2045(11)70275-3_bib19) 2000; 16 Gottardo (10.1016/S1470-2045(11)70275-3_bib50) 2006; 8 Yoon (10.1016/S1470-2045(11)70275-3_bib18) 1999; 41 Durand (10.1016/S1470-2045(11)70275-3_bib52) 2009; 95 Perry (10.1016/S1470-2045(11)70275-3_bib53) 2006 Tufan (10.1016/S1470-2045(11)70275-3_bib27) 2005; 41 Baumgartner (10.1016/S1470-2045(11)70275-3_bib13) 1996; 29 Rushing (10.1016/S1470-2045(11)70275-3_bib26) 2005; 103 Liu (10.1016/S1470-2045(11)70275-3_bib31) 2008; 44 Hope (10.1016/S1470-2045(11)70275-3_bib43) 1992; 13 Gao (10.1016/S1470-2045(11)70275-3_bib36) 2009; 25 Wisoff (10.1016/S1470-2045(11)70275-3_bib47) 1998; 89 Alexiou (10.1016/S1470-2045(11)70275-3_bib34) 2008; 44 Raaschou-Nielsen (10.1016/S1470-2045(11)70275-3_bib28) 2006; 95 Arivazhagan (10.1016/S1470-2045(11)70275-3_bib30) 2008; 44 Mallucci (10.1016/S1470-2045(11)70275-3_bib15) 1996; 12 Menon (10.1016/S1470-2045(11)70275-3_bib35) 2009; 151 Lund-Johansen (10.1016/S1470-2045(11)70275-3_bib22) 2001; 17 Goutagny (10.1016/S1470-2045(11)70275-3_bib54) 2010; 99 Davidson (10.1016/S1470-2045(11)70275-3_bib6) 1989; 63 Turgut (10.1016/S1470-2045(11)70275-3_bib16) 1997; 11 Wolff (10.1016/S1470-2045(11)70275-3_bib48) 2002; 87 Mandai (10.1016/S1470-2045(11)70275-3_bib17) 1997; 25 Kotecha (10.1016/S1470-2045(11)70275-3_bib2) 2011; 104 Choux (10.1016/S1470-2045(11)70275-3_bib7) 1991 Lakhdar (10.1016/S1470-2045(11)70275-3_bib39) 2010; 56 Gondi (10.1016/S1470-2045(11)70275-3_bib56) 2010; 99 Teixidor (10.1016/S1470-2045(11)70275-3_bib32) 2008; 19 Ferrante (10.1016/S1470-2045(11)70275-3_bib5) 1989; 5 Maranhão-Filho (10.1016/S1470-2045(11)70275-3_bib33) 2008; 39 Louis (10.1016/S1470-2045(11)70275-3_bib45) 2007; 114 Perry (10.1016/S1470-2045(11)70275-3_bib23) 2001; 60 Mehta (10.1016/S1470-2045(11)70275-3_bib38) 2009; 4 Ferrante (10.1016/S1470-2045(11)70275-3_bib40) 1989; 3 22094005 - Lancet Oncol. 2011 Dec;12(13):1180-1 |
| References_xml | – volume: 22 start-page: 13 year: 2008 end-page: 25 ident: bib3 article-title: Children's cancer and leukaemia group (CCLG): guidelines for the management of intracranial meningioma in children and young people publication-title: Br J Neurosurg – volume: 44 start-page: 373 year: 2008 end-page: 375 ident: bib34 article-title: Intracranial meningiomas in children: report of 8 cases publication-title: Pediatr Neurosurg – volume: 87 start-page: 1086 year: 2002 end-page: 1091 ident: bib48 article-title: Choroid plexus tumours publication-title: Br J Cancer – volume: 19 start-page: 434 year: 2008 end-page: 439 ident: bib32 article-title: Intracranial meningiomas in children: report of 10 cases publication-title: Neurocirugia – start-page: 56 year: 1938 end-page: 73 ident: bib1 article-title: Serial enumeration of meningiomas publication-title: Meningiomas: their classification, regional behaviour, life history, and surgical end results – volume: 24 start-page: 199 year: 2002 end-page: 204 ident: bib24 article-title: Meningiomas in children and adolescents publication-title: J Pediatr Hematol Oncol – volume: 99 start-page: 393 year: 2010 end-page: 405 ident: bib57 article-title: Intracranial meningiomas of atypical (WHO grade II) histology publication-title: J Neurooncol – volume: 5 start-page: 83 year: 1989 end-page: 86 ident: bib5 article-title: Cerebral meningiomas in children publication-title: Childs Nerv Syst – volume: 95 start-page: 367 year: 2009 end-page: 375 ident: bib52 article-title: WHO grade II and III meningiomas: a study of prognostic factors publication-title: J Neurooncol – volume: 35 start-page: 495 year: 1994 end-page: 501 ident: bib12 article-title: Intracranial meningiomas in childhood publication-title: Acta Paediatr Sin – volume: 80 start-page: 447 year: 1994 end-page: 453 ident: bib11 article-title: Intracranial meningiomas of the first two decades of life publication-title: J Neurosurg – volume: 10 start-page: 258 year: 2009 end-page: 266 ident: bib46 article-title: Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study publication-title: Lancet Oncol – volume: 63 start-page: 1205 year: 1989 end-page: 1210 ident: bib6 article-title: Meningeal tumors of childhood publication-title: Cancer – volume: 20 start-page: 207 year: 1994 end-page: 213 ident: bib42 article-title: Meningeal tumors in children publication-title: Pediatr Neurosurg – volume: 13 start-page: 112 year: 1995 end-page: 123 ident: bib51 article-title: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen publication-title: J Clin Oncol – start-page: 432 year: 2006 end-page: 440 ident: bib53 article-title: Meningiomas publication-title: Russell & Rubenstein's pathology of tumors of the nervous system – volume: 25 start-page: 131 year: 1997 end-page: 136 ident: bib17 article-title: The clinical analysis of pediatric meningioma: 5 cases publication-title: No Shinkei Geka – volume: 60 start-page: 994 year: 2001 end-page: 1003 ident: bib23 article-title: Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases publication-title: J Neuropathol Exp Neurol – volume: 13 start-page: 1353 year: 1992 end-page: 1364 ident: bib43 article-title: Primary meningeal tumors in children: correlation of clinical and CT findings with histologic type and prognosis publication-title: Am J Neuroradiol – volume: 99 start-page: 341 year: 2010 end-page: 347 ident: bib54 article-title: Meningiomas and neurofibromatosis publication-title: J Neurooncol – volume: 99 start-page: 433 year: 2010 end-page: 443 ident: bib58 article-title: A review of malignant meningiomas: diagnosis, characteristics, and treatment publication-title: J Neurooncol – volume: 17 start-page: 719 year: 2001 end-page: 723 ident: bib22 article-title: Neurosurgical treatment of meningiomas in children and young adults publication-title: Childs Nerv Syst – volume: 8 start-page: 319 year: 2006 end-page: 334 ident: bib50 article-title: Current therapy for medulloblastoma publication-title: Curr Treat Options Neurol – volume: 18 start-page: 16 year: 1992 end-page: 23 ident: bib8 article-title: Childhood meningiomas: experience in the modern imaging era publication-title: Pediatr Neurosurg – volume: 95 start-page: 416 year: 2006 end-page: 422 ident: bib28 article-title: Increasing incidence of childhood tumours of the central nervous system in Denmark, 1980–1996 publication-title: Br J Cancer – volume: 16 start-page: 406 year: 2000 end-page: 416 ident: bib19 article-title: Meningiomas of the central nervous system occurring below the age of 17: report of 24 cases not associated with neurofibromatosis and review of literature publication-title: Childs Nerv Syst – volume: 17 start-page: 832 year: 1999 end-page: 845 ident: bib49 article-title: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study publication-title: J Clin Oncol – start-page: 93 year: 1991 end-page: 102 ident: bib7 article-title: Meningiomas in children publication-title: Meningiomas and their surgical management – volume: 100 start-page: 179 year: 2004 end-page: 182 ident: bib25 article-title: Long-term follow up of children with meningiomas in Denmark: 1935 to 1984 publication-title: J Neurosurg – volume: 39 start-page: 415 year: 2008 end-page: 417 ident: bib33 article-title: Intracranial meningiomas in children: ten-year experience publication-title: Pediatr Neurol – volume: 49 start-page: 136 year: 1998 end-page: 141 ident: bib44 article-title: Intracranial meningiomas in children: review of 29 cases publication-title: Surg Neurol – volume: 56 start-page: 309 year: 2010 end-page: 314 ident: bib39 article-title: Intracranial meningioma in children: different from adult forms? A series of 21 cases publication-title: Neurochirurgie – volume: 15 start-page: 435 year: 1994 end-page: 444 ident: bib10 article-title: MR of pediatric intracranial meningiomas publication-title: Am J Neuroradiol – volume: 41 start-page: 512 year: 1999 end-page: 516 ident: bib18 article-title: I of primary meningeal tumours in children publication-title: Neuroradiology – volume: 17 start-page: 656 year: 2001 end-page: 662 ident: bib21 article-title: Childhood meningioma: unusual location, atypical radiological findings, and favorable treatment outcome publication-title: Childs Nerv Syst – volume: 44 start-page: 43 year: 2008 end-page: 48 ident: bib30 article-title: Pediatric intracranial meningiomas—do they differ from their counterparts in adults? publication-title: Pediatr Neurosurg – volume: 151 start-page: 65 year: 2009 end-page: 94 ident: bib4 article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration publication-title: Ann Intern Med – volume: 29 start-page: 223 year: 1996 end-page: 228 ident: bib13 article-title: Meningioma in the pediatric population publication-title: J Neurooncol – volume: 103 start-page: 489 year: 2005 end-page: 495 ident: bib26 article-title: Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients publication-title: J Neurosurg – volume: 104 start-page: 1 year: 2011 end-page: 10 ident: bib2 article-title: Pediatric meningioma – current approaches and future direction publication-title: J Neurooncol – volume: 44 start-page: 112 year: 2008 end-page: 117 ident: bib31 article-title: Clinical features and treatment of meningiomas in children: report of 12 cases and literature review publication-title: Pediatr Neurosurg – volume: 21 start-page: 31 year: 2006 end-page: 36 ident: bib41 article-title: Intracranial meningiomas in children: report of 27 new cases and critical analysis of 440 cases reported in the literature publication-title: J Child Neurol – volume: 99 start-page: 349 year: 2010 end-page: 356 ident: bib56 article-title: Fractionated radiotherapy for intracranial meningiomas publication-title: J Neurooncol – volume: 4 start-page: 61 year: 2009 end-page: 65 ident: bib38 article-title: Meningiomas in children: a study of 18 cases publication-title: J Pediatr Neurosci – volume: 89 start-page: 52 year: 1998 end-page: 59 ident: bib47 article-title: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945 publication-title: J Neurosurg – volume: 25 start-page: 1571 year: 2009 end-page: 1580 ident: bib36 article-title: Childhood and juvenile meningiomas publication-title: Childs Nerv Syst – volume: 3 start-page: 189 year: 1989 end-page: 196 ident: bib40 article-title: Paediatric intracranial meningiomas publication-title: Br J Neurosurg – volume: 151 start-page: 239 year: 2009 end-page: 244 ident: bib35 article-title: Childhood and adolescent meningiomas: a report of 38 cases and review of literature publication-title: Acta Neurochir – volume: 196 start-page: 151 year: 2000 end-page: 158 ident: bib20 article-title: Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry publication-title: Pathol Res Pract – volume: 11 start-page: 501 year: 1997 end-page: 507 ident: bib16 article-title: Meningiomas in childhood and adolescence: a report of 13 cases and review of the literature publication-title: Br J Neurosurg – volume: 14 start-page: 237 year: 1993 end-page: 241 ident: bib9 article-title: Meningiomas in children: MR and histopathologic findings publication-title: Am J Neuroradiol – volume: 45 start-page: 328 year: 1996 end-page: 335 ident: bib14 article-title: Meningioma in children: a report of nine cases and review of the literature publication-title: Surg Neurol – volume: 41 start-page: 1 year: 2005 end-page: 7 ident: bib27 article-title: Intracranial meningiomas of childhood and adolescence publication-title: Pediatr Neurosurg – volume: 361 start-page: 358 year: 2009 end-page: 367 ident: bib55 article-title: Hearing improvement after bevacizumab in patients with neurofibromatosis type 2 publication-title: N Engl J Med – volume: 12 start-page: 582 year: 1996 end-page: 589 ident: bib15 article-title: Paediatric meningeal tumours publication-title: Childs Nerv Syst – volume: 25 start-page: 1411 year: 2009 end-page: 1417 ident: bib37 article-title: Intracranial meningiomas of childhood and adolescence: report of 34 cases with follow-up publication-title: Childs Nerv Syst – volume: 44 start-page: 9 year: 2008 end-page: 13 ident: bib29 article-title: Meningiomas in children publication-title: Pediatr Neurosurg – volume: 114 start-page: 97 year: 2007 end-page: 109 ident: bib45 article-title: The 2007 WHO classification of tumours of the central nervous system publication-title: Acta Neuropathol – volume: 13 start-page: 112 year: 1995 ident: 10.1016/S1470-2045(11)70275-3_bib51 article-title: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen publication-title: J Clin Oncol doi: 10.1200/JCO.1995.13.1.112 – start-page: 56 year: 1938 ident: 10.1016/S1470-2045(11)70275-3_bib1 article-title: Serial enumeration of meningiomas – volume: 5 start-page: 83 year: 1989 ident: 10.1016/S1470-2045(11)70275-3_bib5 article-title: Cerebral meningiomas in children publication-title: Childs Nerv Syst doi: 10.1007/BF00571115 – volume: 41 start-page: 512 year: 1999 ident: 10.1016/S1470-2045(11)70275-3_bib18 article-title: I of primary meningeal tumours in children publication-title: Neuroradiology doi: 10.1007/s002340050794 – volume: 151 start-page: 239 year: 2009 ident: 10.1016/S1470-2045(11)70275-3_bib35 article-title: Childhood and adolescent meningiomas: a report of 38 cases and review of literature publication-title: Acta Neurochir doi: 10.1007/s00701-009-0206-8 – volume: 60 start-page: 994 year: 2001 ident: 10.1016/S1470-2045(11)70275-3_bib23 article-title: Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases publication-title: J Neuropathol Exp Neurol doi: 10.1093/jnen/60.10.994 – volume: 17 start-page: 832 year: 1999 ident: 10.1016/S1470-2045(11)70275-3_bib49 article-title: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study publication-title: J Clin Oncol doi: 10.1200/JCO.1999.17.3.832 – volume: 151 start-page: 65 year: 2009 ident: 10.1016/S1470-2045(11)70275-3_bib4 article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration publication-title: Ann Intern Med doi: 10.7326/0003-4819-151-4-200908180-00136 – volume: 8 start-page: 319 year: 2006 ident: 10.1016/S1470-2045(11)70275-3_bib50 article-title: Current therapy for medulloblastoma publication-title: Curr Treat Options Neurol doi: 10.1007/s11940-006-0022-x – volume: 361 start-page: 358 year: 2009 ident: 10.1016/S1470-2045(11)70275-3_bib55 article-title: Hearing improvement after bevacizumab in patients with neurofibromatosis type 2 publication-title: N Engl J Med doi: 10.1056/NEJMoa0902579 – volume: 100 start-page: 179 issue: suppl 2 year: 2004 ident: 10.1016/S1470-2045(11)70275-3_bib25 article-title: Long-term follow up of children with meningiomas in Denmark: 1935 to 1984 publication-title: J Neurosurg – volume: 41 start-page: 1 year: 2005 ident: 10.1016/S1470-2045(11)70275-3_bib27 article-title: Intracranial meningiomas of childhood and adolescence publication-title: Pediatr Neurosurg doi: 10.1159/000084858 – volume: 104 start-page: 1 year: 2011 ident: 10.1016/S1470-2045(11)70275-3_bib2 article-title: Pediatric meningioma – current approaches and future direction publication-title: J Neurooncol doi: 10.1007/s11060-010-0503-3 – volume: 35 start-page: 495 year: 1994 ident: 10.1016/S1470-2045(11)70275-3_bib12 article-title: Intracranial meningiomas in childhood publication-title: Acta Paediatr Sin – volume: 44 start-page: 373 year: 2008 ident: 10.1016/S1470-2045(11)70275-3_bib34 article-title: Intracranial meningiomas in children: report of 8 cases publication-title: Pediatr Neurosurg doi: 10.1159/000149903 – volume: 44 start-page: 112 year: 2008 ident: 10.1016/S1470-2045(11)70275-3_bib31 article-title: Clinical features and treatment of meningiomas in children: report of 12 cases and literature review publication-title: Pediatr Neurosurg doi: 10.1159/000113112 – volume: 89 start-page: 52 year: 1998 ident: 10.1016/S1470-2045(11)70275-3_bib47 article-title: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945 publication-title: J Neurosurg doi: 10.3171/jns.1998.89.1.0052 – volume: 13 start-page: 1353 year: 1992 ident: 10.1016/S1470-2045(11)70275-3_bib43 article-title: Primary meningeal tumors in children: correlation of clinical and CT findings with histologic type and prognosis publication-title: Am J Neuroradiol – volume: 114 start-page: 97 year: 2007 ident: 10.1016/S1470-2045(11)70275-3_bib45 article-title: The 2007 WHO classification of tumours of the central nervous system publication-title: Acta Neuropathol doi: 10.1007/s00401-007-0243-4 – volume: 17 start-page: 656 year: 2001 ident: 10.1016/S1470-2045(11)70275-3_bib21 article-title: Childhood meningioma: unusual location, atypical radiological findings, and favorable treatment outcome publication-title: Childs Nerv Syst doi: 10.1007/s003810100507 – volume: 24 start-page: 199 year: 2002 ident: 10.1016/S1470-2045(11)70275-3_bib24 article-title: Meningiomas in children and adolescents publication-title: J Pediatr Hematol Oncol doi: 10.1097/00043426-200203000-00008 – volume: 39 start-page: 415 year: 2008 ident: 10.1016/S1470-2045(11)70275-3_bib33 article-title: Intracranial meningiomas in children: ten-year experience publication-title: Pediatr Neurol doi: 10.1016/j.pediatrneurol.2008.08.004 – volume: 49 start-page: 136 year: 1998 ident: 10.1016/S1470-2045(11)70275-3_bib44 article-title: Intracranial meningiomas in children: review of 29 cases publication-title: Surg Neurol doi: 10.1016/S0090-3019(97)00343-1 – volume: 95 start-page: 367 year: 2009 ident: 10.1016/S1470-2045(11)70275-3_bib52 article-title: WHO grade II and III meningiomas: a study of prognostic factors publication-title: J Neurooncol doi: 10.1007/s11060-009-9934-0 – volume: 45 start-page: 328 year: 1996 ident: 10.1016/S1470-2045(11)70275-3_bib14 article-title: Meningioma in children: a report of nine cases and review of the literature publication-title: Surg Neurol doi: 10.1016/0090-3019(95)00451-3 – volume: 29 start-page: 223 year: 1996 ident: 10.1016/S1470-2045(11)70275-3_bib13 article-title: Meningioma in the pediatric population publication-title: J Neurooncol doi: 10.1007/BF00165652 – volume: 17 start-page: 719 year: 2001 ident: 10.1016/S1470-2045(11)70275-3_bib22 article-title: Neurosurgical treatment of meningiomas in children and young adults publication-title: Childs Nerv Syst doi: 10.1007/s00381-001-0516-5 – volume: 20 start-page: 207 year: 1994 ident: 10.1016/S1470-2045(11)70275-3_bib42 article-title: Meningeal tumors in children publication-title: Pediatr Neurosurg doi: 10.1159/000120790 – volume: 80 start-page: 447 year: 1994 ident: 10.1016/S1470-2045(11)70275-3_bib11 article-title: Intracranial meningiomas of the first two decades of life publication-title: J Neurosurg doi: 10.3171/jns.1994.80.3.0447 – volume: 87 start-page: 1086 year: 2002 ident: 10.1016/S1470-2045(11)70275-3_bib48 article-title: Choroid plexus tumours publication-title: Br J Cancer doi: 10.1038/sj.bjc.6600609 – volume: 4 start-page: 61 year: 2009 ident: 10.1016/S1470-2045(11)70275-3_bib38 article-title: Meningiomas in children: a study of 18 cases publication-title: J Pediatr Neurosci doi: 10.4103/1817-1745.57322 – volume: 44 start-page: 9 year: 2008 ident: 10.1016/S1470-2045(11)70275-3_bib29 article-title: Meningiomas in children publication-title: Pediatr Neurosurg doi: 10.1159/000110656 – start-page: 93 year: 1991 ident: 10.1016/S1470-2045(11)70275-3_bib7 article-title: Meningiomas in children – volume: 25 start-page: 1571 year: 2009 ident: 10.1016/S1470-2045(11)70275-3_bib36 article-title: Childhood and juvenile meningiomas publication-title: Childs Nerv Syst doi: 10.1007/s00381-009-0964-x – volume: 99 start-page: 433 year: 2010 ident: 10.1016/S1470-2045(11)70275-3_bib58 article-title: A review of malignant meningiomas: diagnosis, characteristics, and treatment publication-title: J Neurooncol doi: 10.1007/s11060-010-0348-9 – volume: 25 start-page: 1411 year: 2009 ident: 10.1016/S1470-2045(11)70275-3_bib37 article-title: Intracranial meningiomas of childhood and adolescence: report of 34 cases with follow-up publication-title: Childs Nerv Syst doi: 10.1007/s00381-009-0949-9 – volume: 99 start-page: 349 year: 2010 ident: 10.1016/S1470-2045(11)70275-3_bib56 article-title: Fractionated radiotherapy for intracranial meningiomas publication-title: J Neurooncol doi: 10.1007/s11060-010-0368-5 – volume: 18 start-page: 16 year: 1992 ident: 10.1016/S1470-2045(11)70275-3_bib8 article-title: Childhood meningiomas: experience in the modern imaging era publication-title: Pediatr Neurosurg doi: 10.1159/000120637 – volume: 95 start-page: 416 year: 2006 ident: 10.1016/S1470-2045(11)70275-3_bib28 article-title: Increasing incidence of childhood tumours of the central nervous system in Denmark, 1980–1996 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6603278 – volume: 99 start-page: 341 year: 2010 ident: 10.1016/S1470-2045(11)70275-3_bib54 article-title: Meningiomas and neurofibromatosis publication-title: J Neurooncol doi: 10.1007/s11060-010-0339-x – volume: 12 start-page: 582 year: 1996 ident: 10.1016/S1470-2045(11)70275-3_bib15 article-title: Paediatric meningeal tumours publication-title: Childs Nerv Syst doi: 10.1007/BF00261651 – volume: 10 start-page: 258 year: 2009 ident: 10.1016/S1470-2045(11)70275-3_bib46 article-title: Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study publication-title: Lancet Oncol doi: 10.1016/S1470-2045(08)70342-5 – volume: 63 start-page: 1205 year: 1989 ident: 10.1016/S1470-2045(11)70275-3_bib6 article-title: Meningeal tumors of childhood publication-title: Cancer doi: 10.1002/1097-0142(19890315)63:6<1205::AID-CNCR2820630627>3.0.CO;2-U – volume: 22 start-page: 13 year: 2008 ident: 10.1016/S1470-2045(11)70275-3_bib3 article-title: Children's cancer and leukaemia group (CCLG): guidelines for the management of intracranial meningioma in children and young people publication-title: Br J Neurosurg doi: 10.1080/02688690701842208 – volume: 25 start-page: 131 year: 1997 ident: 10.1016/S1470-2045(11)70275-3_bib17 article-title: The clinical analysis of pediatric meningioma: 5 cases publication-title: No Shinkei Geka – volume: 19 start-page: 434 year: 2008 ident: 10.1016/S1470-2045(11)70275-3_bib32 article-title: Intracranial meningiomas in children: report of 10 cases publication-title: Neurocirugia doi: 10.1016/S1130-1473(08)70210-0 – start-page: 432 year: 2006 ident: 10.1016/S1470-2045(11)70275-3_bib53 article-title: Meningiomas – volume: 44 start-page: 43 year: 2008 ident: 10.1016/S1470-2045(11)70275-3_bib30 article-title: Pediatric intracranial meningiomas—do they differ from their counterparts in adults? publication-title: Pediatr Neurosurg doi: 10.1159/000110661 – volume: 196 start-page: 151 year: 2000 ident: 10.1016/S1470-2045(11)70275-3_bib20 article-title: Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry publication-title: Pathol Res Pract doi: 10.1016/S0344-0338(00)80095-3 – volume: 103 start-page: 489 issue: suppl 6 year: 2005 ident: 10.1016/S1470-2045(11)70275-3_bib26 article-title: Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients publication-title: J Neurosurg – volume: 21 start-page: 31 year: 2006 ident: 10.1016/S1470-2045(11)70275-3_bib41 article-title: Intracranial meningiomas in children: report of 27 new cases and critical analysis of 440 cases reported in the literature publication-title: J Child Neurol doi: 10.1177/08830738060210010801 – volume: 99 start-page: 393 year: 2010 ident: 10.1016/S1470-2045(11)70275-3_bib57 article-title: Intracranial meningiomas of atypical (WHO grade II) histology publication-title: J Neurooncol doi: 10.1007/s11060-010-0343-1 – volume: 15 start-page: 435 year: 1994 ident: 10.1016/S1470-2045(11)70275-3_bib10 article-title: MR of pediatric intracranial meningiomas publication-title: Am J Neuroradiol – volume: 11 start-page: 501 year: 1997 ident: 10.1016/S1470-2045(11)70275-3_bib16 article-title: Meningiomas in childhood and adolescence: a report of 13 cases and review of the literature publication-title: Br J Neurosurg doi: 10.1080/02688699745655 – volume: 56 start-page: 309 year: 2010 ident: 10.1016/S1470-2045(11)70275-3_bib39 article-title: Intracranial meningioma in children: different from adult forms? A series of 21 cases publication-title: Neurochirurgie doi: 10.1016/j.neuchi.2010.05.008 – volume: 3 start-page: 189 year: 1989 ident: 10.1016/S1470-2045(11)70275-3_bib40 article-title: Paediatric intracranial meningiomas publication-title: Br J Neurosurg doi: 10.3109/02688698909002794 – volume: 16 start-page: 406 year: 2000 ident: 10.1016/S1470-2045(11)70275-3_bib19 article-title: Meningiomas of the central nervous system occurring below the age of 17: report of 24 cases not associated with neurofibromatosis and review of literature publication-title: Childs Nerv Syst doi: 10.1007/s003819900205 – volume: 14 start-page: 237 year: 1993 ident: 10.1016/S1470-2045(11)70275-3_bib9 article-title: Meningiomas in children: MR and histopathologic findings publication-title: Am J Neuroradiol – reference: 22094005 - Lancet Oncol. 2011 Dec;12(13):1180-1 |
| SSID | ssj0017105 |
| Score | 2.4286551 |
| SecondaryResourceType | review_article |
| Snippet | The epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been drawn from small... Summary Background The epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1229 |
| SubjectTerms | Adolescent Adults Age Factors Child Child, Preschool Children & youth Connective tissue diseases Disease-Free Survival Female Hematology, Oncology and Palliative Medicine Histology Humans Infant Kaplan-Meier Estimate Male Medical prognosis Meningeal Neoplasms - mortality Meningeal Neoplasms - pathology Meningeal Neoplasms - surgery Meningioma - mortality Meningioma - pathology Meningioma - surgery Neurosurgical Procedures - adverse effects Neurosurgical Procedures - mortality Patients Proportional Hazards Models Radiation therapy Radiotherapy, Adjuvant Reoperation Risk Assessment Risk Factors Survival analysis Survival Rate Teenagers Time Factors Treatment Outcome Tumors |
| Title | Meningiomas in children and adolescents: a meta-analysis of individual patient data |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1470204511702753 https://www.clinicalkey.es/playcontent/1-s2.0-S1470204511702753 https://dx.doi.org/10.1016/S1470-2045(11)70275-3 https://www.ncbi.nlm.nih.gov/pubmed/22094004 https://www.proquest.com/docview/908423921 https://www.proquest.com/docview/907037055 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwEB1BKyEuiPLVpbTygQMcTDN2Nna4IKhaVUhbIUqlvVmO40iVINuy2__PTOIYDpRyySHJs6WxPZ7xjN8AvG61KkKJQbZVRD66sbKpmyirUFXkjtnYenYUF2fV6UX5eTlfptycdUqrnHTioKjbVeAz8sO6sMxVp_DD1bXkolEcXE0VNO7DNjOXcUaXWWZ_C82YwYilKSSzrv--wHN4nl--QXxrOHYn9W1b022m57AFnTyGR8l2FB_Hwd6Be7F_Ag8WKTr-FM4Xcag_xCk_4rIX00Vt4ftW_EHd9F548SNuvPSJkUSsOnGZb2aJxLUqOHv0GVycHH87OpWpaIIM86LYSHKwQkdyDp2x80ZjVLqMgZYteSbW1I1vlUUy8-q6oe09RNUGbWxtoio8aq_1c9jqV33cBWHn1GSHHbYRS_poja-jrSrS1RrRmxmUk7xcSIziXNjiu8upYyxmx2ImT8MNYnZ6Bu8y7Gqk1LgLUE2D4ab7oqThHCn9u4Dmb8C4Tut07dCtlStGNIO5Dg9BCWkzMpkio4nxP53uTfPF5X7y7J2ByF9pIXN0xvdxdcO_kPJlbqMZvBhnWZaOUsxyWJQv_9n0HjwcDryHXJtXsLX5eRP3yWLaNAfDuqCnPcID2P50fPbl6y8riw01 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VWwm4IN4s5eEDSHAwje1s7CAhxKPVlnZXiLZSb8ZxHKkSZAu7FeJH8R-ZSRzDgVIuvSb5nGgynofnBfC4VjLzufC8LoKgoxvDq7IKvPBFge6YCbUjR3E2L6aH-fujydEa_BxqYSitcpCJnaCuF57OyDfLzFCvOilenXzlNDSKgqvDBI2eK3bDj-_osS1f7rzD3_tEyu2tg7dTHocKcD_JshVHB8Q3-B2-0WZSKRGkyoNHtkbL3eiycrU0As2gsqxQ_fkga6-0KXWQmRPK0fknSvz1XOFCI1h_szX_8DGFLXSfMylynXHq8_67ZGhzP118KsQzTdFCrs5ShmcZu53S274GV6O1yl737HUd1kJ7Ay7NYjz-JuzPQjfxiJKM2HHLhtJw5tqa_dEs6gVz7EtYOe5iDxS2aNhxqgVjsbsro3zVW3B4IRS9DaN20Ya7wMwEl2xEI-ogcrxptCuDKQrUDkoIp8eQD_SyPvYwp1Ean21KViMyWyIz-ja2I7NVY3ieYCd9E4_zAMXwM-xQoYoy1aKaOQ-o_wYMyygZllbYpbRZjyYwTf5BKCJNQkbjpzdq_uelGwO_2PSetF_GwNJdFB0UD3JtWJzSIyjuqZvSGO70XJaoIyX1Vczye_9c-hFcnh7M9uzeznx3A650x-1dps99GK2-nYYHaK-tqodxlzD4dNEb8xc9gEbR |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRaq4IN4s5eEDSHAwG9tJ7CAhhCirlrIVUqm0N-M4jlSpZAu7FeKn8e-YSRzDgVIuvSb5kmg8T3seAE8aJTOfC8-bMgjaujG8rurAS1-WGI6Z0DgKFOcH5e5R_n5RLDbg51gLQ2mVo07sFXWz9LRHPq0yQ73qpJi2MSvi487s9elXTgOk6KB1nKYxcMh--PEdo7fVq70dXOqnUs7efXq7y-OAAe6LLFtzDEZ8i__kW22KWokgVR48sjh68UZXtWukEegSVVWNptAH2XilTaWDzJxQjvZCUftf0aoQJGJ6kWI9oYfsSZHrjFPH99_FQ9PDdPGZEM81nRtydZ5ZPM_t7c3f7Dpci34rezMw2g3YCN1N2JrHk_lbcDgP_ewjSjdixx0bi8SZ6xr2R9uol8yxL2HtuIvdUNiyZcepKozFPq-MMldvw9Gl0PMObHbLLtwDZgp8ZSta0QSR402jXRVMWaKdUEI4PYF8pJf1sZs5DdU4sSltjchsicwY5diezFZN4EWCnQ7tPC4ClONi2LFWFbWrRYNzEVD_DRhWUUesrLArabMBTWCaAYRQRJqEjG7Q4N78z0e3R36x6TtJcibA0l1UInQy5LqwPKNHUPFTX6UJ3B24LFFHSuqwmOX3__nqx7CF4mg_7B3sb8PVft-9T_l5AJvrb2fhITpu6_pRLyIMPl-2TP4CYidJoQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Meningiomas+in+children+and+adolescents%3A+a+meta-analysis+of+individual+patient+data&rft.jtitle=The+lancet+oncology&rft.au=Kotecha%2C+Rishi+S&rft.au=Pascoe%2C+Elaine+M&rft.au=Rushing%2C+Elisabeth+J&rft.au=Rorke-Adams%2C+Lucy+B&rft.date=2011-12-01&rft.pub=Elsevier+Limited&rft.issn=1470-2045&rft.eissn=1474-5488&rft.volume=12&rft.issue=13&rft.spage=1229&rft_id=info:doi/10.1016%2FS1470-2045%2811%2970275-3&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=2526905141 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F14702045%2FS1470204511X71322%2Fcov150h.gif |